Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zicam Sales Up, Matrixx Cuts Loss With Legal Expenses Down More Than Half

This article was originally published in The Tan Sheet

Executive Summary

High sales of Matrixx Initiatives' Zicam line in an out-of-season quarter helped the OTC manufacturer increase cold and cough product sales, the firm said

You may also be interested in...



Zinc Gluconate Sprays Challenged In Lawsuits; Matrixx Defends Zicam Safety

The safety of zinc gluconate sprays has been called into question by a recent spate of lawsuits alleging that the products cause users to lose their sense of smell

FTC Views Testimonials As Efficacy Claims, Senior Attorney Warns

The Federal Trade Commission's senior staff attorney for advertising practices recommends firms stay away from using consumer testimonials to assert the benefits of their products

FTC Views Testimonials As Efficacy Claims, Senior Attorney Warns

The Federal Trade Commission's senior staff attorney for advertising practices recommends firms stay away from using consumer testimonials to assert the benefits of their products

Topics

UsernamePublicRestriction

Register

PS100764

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel